$SGRY Income Statement | Understand Stock

$SGRY

$23.36 +$0.00 (0.0%) After hours

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Operating expenses:
Salaries and benefits
Supplies
Professional and medical fees
Lease expense
Other operating expenses
Cost of revenues
General and administrative expenses
Depreciation and amortization
Transaction and integration costs
Grant funds
Net loss on disposals, consolidations and deconsolidations
Equity in earnings of unconsolidated affiliates
Litigation settlements
Loss on debt extinguishment
Impairment charges
Other income, net
Total operating expenses

Operating income
Tax receivable agreement expense
Interest expense, net
Income before income taxes
Income tax (expense) benefit
Net income
Less: Net income attributable to non-controlling interests
Net loss attributable to Surgery Partners, Inc.
Less: Amounts attributable to participating securities
Net loss attributable to common stockholders
Net loss per share attributable to common stockholders:
Basic (in USD per share)
Diluted (in USD per share)
Weighted average common shares outstanding:
Basic (shares)
Diluted (shares)

Comments